Critical Analysis: TerrAscend (TRSSF) versus The Competition

TerrAscend (OTCMKTS:TRSSFGet Rating) is one of 32 publicly-traded companies in the “Agricultural production – crops” industry, but how does it weigh in compared to its rivals? We will compare TerrAscend to similar businesses based on the strength of its risk, profitability, earnings, dividends, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings for TerrAscend and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TerrAscend 0 3 5 0 2.63
TerrAscend Competitors 56 137 440 23 2.66

TerrAscend currently has a consensus target price of $3.57, indicating a potential upside of 100.37%. As a group, “Agricultural production – crops” companies have a potential upside of 63.97%. Given TerrAscend’s higher possible upside, equities analysts clearly believe TerrAscend is more favorable than its rivals.

Institutional & Insider Ownership

0.0% of TerrAscend shares are held by institutional investors. Comparatively, 28.7% of shares of all “Agricultural production – crops” companies are held by institutional investors. 44.3% of TerrAscend shares are held by insiders. Comparatively, 21.5% of shares of all “Agricultural production – crops” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares TerrAscend and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TerrAscend -143.67% -8.24% -3.88%
TerrAscend Competitors -199.08% -18.48% -11.40%

Earnings and Valuation

This table compares TerrAscend and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
TerrAscend $210.42 million $3.11 million -1.33
TerrAscend Competitors $1.63 billion $92.12 million 7.26

TerrAscend’s rivals have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

TerrAscend rivals beat TerrAscend on 7 of the 12 factors compared.

About TerrAscend

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.